Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer

by Amparo Burgos-San José, Claudia Colomer-Aguilar, Daniel Martínez-Caballero, Bartomeu Massutí-Sureda
Published 2021-05-01

Consensus to identify the dangerous drugs risks in hospital pharmacy services

by María Ángeles Bernabeu-Martínez, Pedro García-Salom, Amparo Burgos-San José, Andrés Navarro-Ruiz, Javier Sanz-Valero, Carmina Wanden-Berghe
Published 2020-03-01

Observational study of clinical toxicity with different formulations of docetaxel in breast cancer patients

by Eva González-Haba-Peña, Margarita Garrido-Siles, María Jose Martínez-Bautista, Amparo Burgos-San José, Azucena Aldaz-Pastor, Irene Mangues-Bafalluy
Published 2020-09-01

Ocrelizumab in Multiple Sclerosis: A Real-World Study From Spain

by Angel P. Sempere, Angel P. Sempere, Leticia Berenguer-Ruiz, Ines Borrego-Soriano, Amparo Burgos-San Jose, Luis Concepcion-Aramendia, Lucian Volar, Miguel Aragones, Antonio Palazón-Bru
Published 2021-01-01